DeepMed Research

Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics

Not Applicable

Completed

Conditions: Gestational Diabetes

Interventions: Other: 2 hour blood glucose monitoring
Other: 1 hour Blood glucose monitoring

First Posted Date: 2021-09-30

Last Posted Date: 2025-05-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 140

Registration Number: NCT05062460

Locations: 🇺🇸
New York Prebyterian Hospital Weill Cornell, New York, New York, United States

SPIROMICS Study of Early COPD Progression (SOURCE)

Recruiting

Conditions: COPD, Early-Onset

First Posted Date: 2021-09-05

Last Posted Date: 2025-02-24

Lead Sponsor: University of Massachusetts, Worcester

Target Recruit Count: 1000

Registration Number: NCT05033990

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸
University of California Los Angeles, Los Angeles, California, United States

and more 11 locations

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

Phase 2

Recruiting

Conditions: Rectal Cancer

Interventions: Drug: Etrumadenant (AB928)
Radiation: Radiation therapy
Drug: FOLFOX regimen
Drug: Zimberelimab (AB122)

First Posted Date: 2021-08-27

Last Posted Date: 2024-10-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 43

Registration Number: NCT05024097

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
Brooklyn Methodist Hospital - NewYork Presbyterian, New York, New York, United States
🇺🇸
New York Presbyterian Hospital - Queens, New York, New York, United States

N-of-1 for Beta-Blockers in Cardiac Amyloidosis

Phase 4

Conditions: Cardiac Amyloidosis
Heart Diseases
TTR Cardiac Amyloidosis

Interventions: Drug: Beta blocker

First Posted Date: 2021-08-24

Last Posted Date: 2025-05-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT05019027

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery

Phase 1

Active, not recruiting

Conditions: Atypical Choroid Plexus Papilloma
Choroid Plexus Carcinoma

Interventions: Drug: Melphalan
Drug: Carboplatin
Drug: Topotecan

First Posted Date: 2021-08-06

Last Posted Date: 2025-04-06

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1

Registration Number: NCT04994977

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease

Early Phase 1

Withdrawn

Conditions: Amyloid
Amyloidosis
AL Amyloidosis

Interventions: Drug: Selinexor
Drug: Dexamethasone

First Posted Date: 2021-07-30

Last Posted Date: 2022-11-17

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04984330

Locations: 🇺🇸
Weill Cornell Medicine - Multiple Myeloma Center, New York, New York, United States

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Radiation Therapy

First Posted Date: 2021-07-30

Last Posted Date: 2025-05-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 33

Registration Number: NCT04984343

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇬🇧
Genesis Care, Oxford, United Kingdom

Accelerated TMS for Depression and OCD

Not Applicable

Recruiting

Conditions: Depression
OCD

Interventions: Device: MagVenture MagPro System with Brainsight neuronavigation device

First Posted Date: 2021-07-29

Last Posted Date: 2025-03-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 500

Registration Number: NCT04982757

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis

Not Applicable

Recruiting

Conditions: Crohn's Disease of Large Intestine
Malignant Neoplasm of Colon

Interventions: Device: Obtaining bowel gas samples

First Posted Date: 2021-07-16

Last Posted Date: 2024-05-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT04964297

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer

Phase 2

Terminated

Conditions: Small-cell Lung Cancer

Interventions: Drug: Carboplatin
Drug: Cisplatin
Drug: Etoposide
Drug: Durvalumab
Radiation: Stereotactic Body Radiotherapy

First Posted Date: 2021-07-06

Last Posted Date: 2024-11-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 6

Registration Number: NCT04951115

Locations: 🇺🇸
New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
New York-Presbyterian Queens, Flushing, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy